Best Blalock–Thomas–Taussig shunt (BT Shunt) Hospitals in Israel

At Rabin Medical Center, Blalock–Thomas–Taussig shunt (BT Shunt) is performed using advanced pediatric cardiac surgery techniques and individualized treatment plans based on the child's heart defect and pulmonary blood flow. Established in 1996, this JCI hospital in Petah Tikva, Israel has 1300 beds and provides comprehensive congenital heart disease services.

A BT Shunt may be recommended for selected infants and children with congenital heart defects in which blood flow to the lungs is significantly reduced. During the procedure, a synthetic vascular graft is placed between a systemic artery and the pulmonary artery to provide an alternative route for blood to reach the lungs. The shunt is generally used as part of staged treatment rather than as a definitive repair of the underlying heart defect. Careful postoperative monitoring helps assess oxygenation and shunt function.

Sheba Medical Center provides specialized Blalock–Thomas–Taussig shunt (BT Shunt) with a focus on pediatric cardiac expertise, precise shunt placement, oxygenation support, and comprehensive congenital heart care. Established in 1948, the JCI hospital is located in Ramat Gan, Israel and operates 1900 beds with modern pediatric cardiac infrastructure.

A Blalock-Thomas-Taussig Shunt is an established palliative surgical technique used to provide pulmonary blood flow in selected children with cyanotic congenital heart disease. During surgery, a conduit is positioned between a systemic artery and the pulmonary artery, allowing oxygen-poor blood to reach the lungs for oxygenation. The procedure does not correct the underlying heart defect and is commonly used as part of a staged treatment strategy. Detailed preoperative cardiac assessment and intensive postoperative monitoring help guide care and identify potential complications.

Kaplan Medical Centre offers advanced Blalock-Thomas-Taussig Shunt (BT Shunt) surgery using modern pediatric cardiac surgical techniques and internationally accepted treatment protocols. Established in 1953, the JCI hospital is located in Rehovot, Israel and has 1100 beds, providing comprehensive congenital heart care for local and international patients.

A Blalock-Thomas-Taussig Shunt (BT Shunt) is a palliative cardiac procedure used in selected children with cyanotic congenital heart defects that result in inadequate pulmonary blood flow. The procedure creates an additional pathway for blood to flow from a systemic artery to the pulmonary arteries, thereby increasing blood flow to the lungs and improving oxygenation. Before surgery, children undergo detailed cardiac evaluation, including echocardiography and other imaging or catheter-based studies when required. Ongoing cardiac monitoring is essential after the procedure.

Tel Aviv Sourasky Medical Center -Ichilov Hospital is a trusted healthcare provider for Blalock–Thomas–Taussig shunt (BT Shunt), offering specialised congenital heart surgery supported by experienced pediatric cardiologists, cardiothoracic surgeons, and intensivists, as well as modern cardiac infrastructure. Established in 1963, the JCI hospital is situated in Tel Aviv, Israel and has 1500 beds.

Blalock-Thomas-Taussig Shunt is a palliative procedure designed to increase pulmonary blood flow in children with certain cyanotic congenital heart conditions. The shunt connects a systemic arterial blood supply to the pulmonary circulation, allowing additional blood to reach the lungs for oxygenation. It may be performed when native pulmonary blood flow is inadequate and is often part of a staged surgical pathway before further corrective or palliative procedures. Echocardiography, cardiac catheterisation, and other investigations may be used to plan treatment.